Search results
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients.
- Better Medicine in the Epoch of Machine Learning - insitro
Our CEO Daphne Koller founded insitro in 2018 to harness...
- Making Medicines Differently - insitro
Daphne Koller. CEO & Founder. A Team Greater Than the Sum of...
- Better Medicine in the Epoch of Machine Learning - insitro
Daphne Koller founded insitro with the audacious goal to use the power of AI to revolutionize drug discovery. Don’t miss her interview with Paul…
- 500+
- Insitro
- 15K
- San Francisco Bay Area
Oct 25, 2023 · Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI technology is able to analyze images of cancerous tissue, a ...
CEO and Founder, insitro - Cited by 111,657 - machine learning - computational biology - computer vision - artificial intelligence
Nov 11, 2019 · Can a giant pile of data beat human expertise in the design of miracle drugs? Daphne Koller and her startup Insitro may come up with a surprising answer.
People also ask
Who is Daphne Koller?
Why did Daphne Koller start Insitro?
How is Insitro building a better drug company?
What is Insitro & how does it work?